DK1631584T3 - Fremgangsmåde til bestemmelse af aktiviteten af gammasekretase - Google Patents

Fremgangsmåde til bestemmelse af aktiviteten af gammasekretase

Info

Publication number
DK1631584T3
DK1631584T3 DK04730223T DK04730223T DK1631584T3 DK 1631584 T3 DK1631584 T3 DK 1631584T3 DK 04730223 T DK04730223 T DK 04730223T DK 04730223 T DK04730223 T DK 04730223T DK 1631584 T3 DK1631584 T3 DK 1631584T3
Authority
DK
Denmark
Prior art keywords
gamma
secretase
protein
cell
val
Prior art date
Application number
DK04730223T
Other languages
Danish (da)
English (en)
Inventor
Edmund Hoppe
Gisela Peraus
Jonathan Rothblatt
Ekkehard Leberer
Luc Mercken
Sylvie Dreisler
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1631584T3 publication Critical patent/DK1631584T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
DK04730223T 2003-05-26 2004-04-29 Fremgangsmåde til bestemmelse af aktiviteten af gammasekretase DK1631584T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20030011807 EP1481987A1 (fr) 2003-05-26 2003-05-26 Méthodes de criblage d'inhibiteurs de la gamma-sécrétase
PCT/EP2004/004550 WO2004104037A1 (fr) 2003-05-26 2004-04-29 Procede de criblage d'inhibiteurs de la gamma-secretase

Publications (1)

Publication Number Publication Date
DK1631584T3 true DK1631584T3 (da) 2008-09-01

Family

ID=33104072

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04730223T DK1631584T3 (da) 2003-05-26 2004-04-29 Fremgangsmåde til bestemmelse af aktiviteten af gammasekretase

Country Status (17)

Country Link
US (1) US7892778B2 (fr)
EP (2) EP1481987A1 (fr)
JP (1) JP4903046B2 (fr)
KR (1) KR101215855B1 (fr)
CN (1) CN1795203B (fr)
AT (1) ATE393779T1 (fr)
AU (1) AU2004241151B2 (fr)
BR (1) BRPI0410736A (fr)
CA (1) CA2526790C (fr)
DE (1) DE602004013440T2 (fr)
DK (1) DK1631584T3 (fr)
ES (1) ES2307012T3 (fr)
IL (1) IL172119A (fr)
MX (1) MXPA05012663A (fr)
NO (1) NO334058B1 (fr)
RU (1) RU2373284C2 (fr)
WO (1) WO2004104037A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007028655A2 (fr) * 2005-09-09 2007-03-15 H. Lundbeck A/S Decouverte de medicament traitant de troubles neurodeveloppementaux et leurs complications
WO2007030937A2 (fr) * 2005-09-16 2007-03-22 Institut De Recherches Cliniques De Montreal/I.R.C.M. Proteines chimeres, lignees cellulaires comprenant celles-ci et dosages pour cribler des modulateurs de proteinase utilisant ces lignees cellulaires
KR100883158B1 (ko) * 2005-10-26 2009-02-10 주식회사 뉴젝스 살아있는 세포에서 단백질분해효소의 활성 측정 방법
JP2007300856A (ja) * 2006-05-11 2007-11-22 Hiroshi Mori アミロイドタンパク質模倣物
WO2008061673A2 (fr) * 2006-11-24 2008-05-29 Synthon B.V. Découverte de médicaments contre le cancer
CN104880441B (zh) * 2015-05-14 2017-12-22 上海皓拓生物技术有限公司 β‑分泌酶特异性抑制剂的筛选方法及其筛选系统
WO2017041037A1 (fr) * 2015-09-04 2017-03-09 The Trustees Of Columbia University In The City Of New York Interruption de l'interaction entre le peptide bêta-amyloïde et des lipides alimentaires

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07132033A (ja) * 1993-11-12 1995-05-23 Hoechst Japan Ltd アルツハイマー病モデルトランスジェニック動物
WO1998015828A1 (fr) * 1996-10-07 1998-04-16 Scios Inc. METHODE D'IDENTIFICATION DES INHIBITEURS DIRECTS DE L'ENZYME η-SECRETASE PRODUISANT LE β-AMYLOIDE
DE19849073A1 (de) * 1998-10-24 2000-04-27 Aventis Pharma Gmbh Transgener C. elegans als Modellorganismus für Untersuchungen zur Alzheimer'schen Krankheit
DE19856261C1 (de) * 1998-12-07 2000-03-30 Hoechst Marion Roussel De Gmbh Aß-Peptid Screening Assay
DE19920514A1 (de) * 1999-05-05 2000-11-16 Boehringer Ingelheim Pharma Methoden zur Auffindung von Proteasen, die spezifisch membrangebundene Substrate spalten
JP4362035B2 (ja) * 2001-05-11 2009-11-11 メディカル リサーチ カウンシル Ｒｈｏｍｂｏｉｄポリペプチドのモジュレーターを同定するアッセイ

Also Published As

Publication number Publication date
EP1631584B1 (fr) 2008-04-30
WO2004104037A1 (fr) 2004-12-02
CA2526790A1 (fr) 2004-12-02
CN1795203B (zh) 2010-06-16
ES2307012T3 (es) 2008-11-16
NO334058B1 (no) 2013-12-02
EP1631584A1 (fr) 2006-03-08
JP4903046B2 (ja) 2012-03-21
EP1481987A1 (fr) 2004-12-01
AU2004241151B2 (en) 2009-04-09
US7892778B2 (en) 2011-02-22
KR20060015312A (ko) 2006-02-16
CN1795203A (zh) 2006-06-28
KR101215855B1 (ko) 2012-12-31
HK1091215A1 (en) 2007-01-12
CA2526790C (fr) 2013-12-24
BRPI0410736A (pt) 2006-06-27
US20050032150A1 (en) 2005-02-10
RU2373284C2 (ru) 2009-11-20
DE602004013440D1 (de) 2008-06-12
AU2004241151A1 (en) 2004-12-02
RU2005140567A (ru) 2006-06-27
MXPA05012663A (es) 2006-05-25
ATE393779T1 (de) 2008-05-15
NO20056029L (no) 2006-02-24
JP2008502302A (ja) 2008-01-31
DE602004013440T2 (de) 2009-05-20
IL172119A (en) 2010-12-30

Similar Documents

Publication Publication Date Title
Pappano et al. Use of Bmp1/Tll1 doubly homozygous null mice and proteomics to identify and validate in vivo substrates of bone morphogenetic protein 1/tolloid-like metalloproteinases
Hönig et al. Regulation of alternative splicing by the ATP-dependent DEAD-box RNA helicase p72
ATE471373T1 (de) Expression von endogenen genen durch homologe rekombination eines vektorkonstruktes mit zellulärer dna
Pekosz et al. Influenza C virus CM2 integral membrane glycoprotein is produced from a polypeptide precursor by cleavage of an internal signal sequence
Price et al. A venom metalloproteinase from the parasitic wasp Eulophus pennicornis is toxic towards its host, tomato moth (Lacanobia oleracae)
NO331251B1 (no) Faktor VII-polypeptidvariant, nukleinsyrekonstruksjon, rekombinant vertscelle, ikke-humant transgent dyr, fremgangsmate for fremstilling av faktor VII-poly¬peptidet, samt anvendelse av et faktor VII-polypeptid til fremstilling av et medi¬kament for behandling av blodningsepisoder
DE60134786D1 (de) Mini-dystrophin nukleinsäure- und peptidsequenzen
Bown et al. Characterization of a digestive carboxypeptidase from the insect pest corn earworm (Helicoverpa armigera) with novel specificity towards C‐terminal glutamate residues
ES2531167T3 (es) Amilasas y glucoamilasas, ácidos nucleicos que las codifican y métodos para formarlas y utilizarlas
Strasser et al. Comparative genomics reveals conservation of filaggrin and loss of caspase‐14 in dolphins
DE602004028514D1 (de) Transkriptionsfaktor aus arabidopis thaliana sowie codierendes gen und verwendung davon
Marelja et al. The four aldehyde oxidases of Drosophila melanogaster have different gene expression patterns and enzyme substrate specificities
DK1631584T3 (da) Fremgangsmåde til bestemmelse af aktiviteten af gammasekretase
ATE236259T1 (de) Herstellung einzelner genprodukte eines chimären fusionsproteins durch spaltung mit überall vorkommenden endoproteasen
HUP0401869A2 (hu) Aminopeptidáz
ATE317899T1 (de) Gefrierschutzproteine aus choristoneura sp., gene und verfahren zu ihrer verwendung
Wei et al. Identification of a new sea urchin ets protein, SpEts4, by yeast one-hybrid screening with the hatching enzyme promoter
WO2005028615A3 (fr) Procedes et compositions permettant de detecter une activite de promoteur et d'exprimer des proteines de fusion
ATE445009T1 (de) Signalpeptid zur herstellung eines polypeptids
NO20055210D0 (no) Inhibitorproteiner av en protease og anvendelse derav
Velayos-Baeza et al. The function of chorein
WO1999047689A3 (fr) Inhibiteurs des proteines d'apoptose dans des vegetaux
Evans et al. Type I antifreeze proteins expressed in snailfish skin are identical to their plasma counterparts
Hartmann et al. The N-terminal region of the α-subunit of the TRAP complex has a conserved cluster of negative charges
WO2004011676A3 (fr) Modele de gene multi-reporter pour criblage toxicologique